Amphiphilic dextran/magnetite nanocomposites as magnetic resonance imaging probes

Chinese Science Bulletin

Volumn 54, Issue 17, 2009, Pages 2925-2933

  Wang, Qiao Ying ^a   Su, Hong Ying ^a   Xia, Chun Chao ^b   Sun, Jia Yu ^b   Liu, Chen ^a   Wang, Zhi Yong ^a   Gong, Qi Yong ^b   Song, Bin ^b   Gao, Fa Bao ^b   Ai, Hua ^a,b   Gu, Zhong Wei ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Contrast agent; Dextran; Magnetic resonance imaging; Micelle; Superparamagnetic iron oxide

Indexed keywords

EID: 77952868840     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-009-0255-7     Document Type: Article

References (37)

1. Feng L, Song Y, Wan M, et al. Research progress of magnetic iron oxide nanoparticles. Chin Sci Bull, 2001, 46: 1321-1325.
2. Yan G., Zhuo R. Research progress of magnetic resonance imaging contrast agents. Chin Sci Bull, 2001, 46: 1233-1237.
3. Bulte J W, Kraitchman D L. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed, 2004, 17: 484-499.
4. Weissleder R, Mahmood U. Molecular imaging. Radiology, 2001, 219: 316-333.
5. Jana N R, Chen Y, Peng X. Size- and shape-controlled magnetic (Cr, Mn, Fe, Co, Ni) oxide nanocrystals via a simple and general approach. Chem Mater, 2004, 16: 3931-3935.
6. Park J, An K, Hwang Y, et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater, 2004, 3: 891-895.
7. Sun S H, Zeng H, Robinson D B, et al. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc, 2004, 126: 273-279.
8. Jun Y W, Huh Y M, Choi J S, et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc, 2005, 127: 5732-5733.
9. Song H T, Choi J S, Huh Y M, et al. Surface modulation of magnetic nanocrystals in the development of highly efficient magnetic resonance probes for intracellular labeling. J Am Chem Soc, 2005, 127: 9992-9993.
10. Kim S W, Kim S, Tracy J B, et al. Phosphine oxide polymer for water-soluble nanoparticles. J Am Chem Soc, 2005, 127: 4556-4557.
11. Kakizawa Y, Kataoka K. Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev, 2002, 54: 203-222.
12. Kwon G S, Okano T. Polymeric micelles as new drug carriers. Adv Drug Deliv Rev, 1996, 21: 107-116.
13. Croy S R, Kwon G S. Polymeric micelles for drug delivery. Curr Pharm Des, 2006, 12: 4669-4684.
14. Nasongkla N, Bey E, Ren J, et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett, 2006, 6: 2427-2430.
15. Nasongkla N, Shuai X, Ai H, et al. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed Engl, 2004, 43: 6323-6327.
16. Shuai X, Ai H, Nasongkla N, et al. Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release, 2004, 98: 415-426.
17. Ai H, Flask C, Weinberg B, et al. Magnetite-loaded polymeric micelles as ultrasensitive magnetic-resonance probes. Adv Mater, 2005, 17: 1949-1952.
18. Dubertret B, Skourides P, Norris D J, et al. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science, 2002, 298: 1759-1762.
19. Gao X, Cui Y, Levenson R M, et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol, 2004, 22: 969-976.
20. Nouvel C, Dubois P, Dellacherie E, et al. Silylation reaction of dextran: effect of experimental conditions on silylation yield, regioselectivity, and chemical stability of silylated dextrans. Biomacromolecules, 2003, 4: 1443-1450.
21. Bajgai M P, Aryal S, Lee D R, et al. Physicochemical characterization of self-assembled poly(epsilon-caprolactone) grafted dextran nanoparticles. Colloid Polym Sci, 2008, 286: 517-524.
22. Ydens I, Rutot, D, Degee, P, et al. Controlled synthesis of poly (epsilon-caprolactone)-grafted dextran copolymers as potential environmentally friendly surfactants. Macromolecules, 2000, 33: 6713-6721.
23. Xie J, Peng S, Brower, N, et al. One-pot synthesis of monodisperse iron oxide nanoparticles for potential biomedical applications. Pure Appl Chem, 2006, 78: 1003-1014.
24. Josephson, L, Lewis J, Jacobs P, et al. The effects of iron oxides on proton relaxivity. Magn Reson Imaging, 1988, 6: 647-653.
25. Ditsch A, Laibinis P E, Wang D I C, et al. Controlled clustering and Enhanced tability of olymer-oated agnetic anoparticles. Langmuir, 2005, 21: 6006-6018.
26. Berret J F, Schonbeck N, Gazeau F, et al. Controlled clustering of superparamagnetic nanoparticles using block copolymers: Design of new contrast agents for magnetic resonance imaging. J Am Chem Soc, 2006, 128: 1755-1761.
27. 2 NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med, 1995, 34: 227-233.
28. Aguirre D A, Behling C A, Alpert, E, et al. Liver fibrosis: Noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology, 2006, 239: 425-437.
29. Kato N, Ihara S, Tsujimoto T, et al. Effect of resovist on rats with different severities of liver cirrhosis. Invest Radiol, 2002, 37: 292-298.
30. Reimer P, Balzer T. Ferucarbotran (Resovist): A new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: Properties, clinical development, and applications. Eur Radiol, 2003, 13: 1266-1276.
31. Wang Y X, Hussain S M, Krestin G P. Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur Radiol, 2001, 11: 2319-2331.
32. Kim S H, Choi D, Lim H K, et al. Detection of hepatic VX2 carcinomas with ferucarbotran-enhanced magnetic resonance imaging in rabbits: Comparison of nine pulse sequences. Eur J Radiol, 2006, 59: 413-423.
33. Reimer P, Muller M, Marx C, et al. Evaluation of the time window for Resovist-enhanced T2-weighted MRI of the liver. Academic radiology, 2002, 9 (Suppl 2): 336-338.
34. Weissleder R, Hahn P F, Stark D D, et al. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging. Radiology, 1998, 169: 399-403.
35. Shamsi K, Balzer T, Saini S, et al. Superparamagnetic iron oxide particles (SH U 555 A): Evaluation of efficacy in three doses for hepatic MR imaging. Radiology, 1998, 206: 365-371.
36. van Beers B E, Sempoux C, Materne R, et al. Biodistribution of ultrasmall iron oxide particles in the rat liver. J Magn Reson Imaging, 2001, 13: 594-599.
37. Moghimi S M, Hunter A C, Murray J C. Long-circulating and target- specific nanoparticles: theory to practice. Pharmacol Rev, 2001, 53: 283-31.